Skip to main content
. Author manuscript; available in PMC: 2010 Mar 3.
Published in final edited form as: Exp Brain Res. 2007 Nov 8;185(3):509–519. doi: 10.1007/s00221-007-1169-8

Table 1.

Clinical data for hemiparetic stroke participants

Participant Age (years) Lesion location FMAa CMSAb Impairment group
S1 51 N/A 14 2 MS
S2 58 N/A 22 2 MS
S3 56 N/A 23 3 MS
S4 57 Thalamus, posterior putamen, posterior limb of internal capsule 24 3 MS
S5 48 Insula, thalamus, basal ganglia, internal capsule 26 3 MS
S6 57 Lateral/posterior frontal lobe, caudate, basal ganglia, internal capsule 43 6 MM
S7 66 Occipital lobe, thalamus, basal ganglia 49 5 MM
S8 38 Temporal lobe, internal capsule 50 7 MM
S9 69 Frontal–parietal cortex and coronal radiata, internal capsule 51 3 MM
S10 65 N/A 58 7 MM

MS moderate-to-severe impairment, MM mild-to-moderate impairment

a

Based on Fugl-Meyer Motor Assessment (FMA) scale (maximum score = 66)

b

Based on the Chedoke-McMaster Stroke Assessment (CMSA) scale (maximum score = 7)